NAA AFADUA ANNOH: Open Payments
NPI 1588140073 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 31 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $397 · 2025 $678
Food & beverage: $588Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $171 |
| Regeneron Healthcare Solutions, Inc. | 4 | $143 |
| ABBVIE INC. | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $68 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Organon LLC | 3 | $35 |
| UCB, Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, OTEZLA, TALTZ, NEMLUVIO, Bimzelx, ILUMYA.
Industry payments across WA — which companies pay providers there.
